A new transient interhalogen species (ICl•−) has been identified in electron pulse irradiated molten chloride salt mixtures. This species has significant implications for the transport of fission-product iodine in molten salt reactor environments.
Molten salts are proposed as liquid fuels or coolants in a new fleet of molten salt nuclear reactors that would have operational and safety advantages over present reactor systems. Under those conditions, the salt will be exposed to high radiation levels, and understanding the chemical effects of radiolysis on the molten salt fuel or coolant is essential to reliable, efficient and sustainable reactor operation. Building this understanding begins with identifying primary salt radiolysis products and characterizing their reactivities, for which we perform high-temperature pulse radiolysis transient absorption spectroscopy at the BNL Laser-Electron Accelerator Facility. Salt mixtures containing monovalent and divalent cations are of particular interest because of their tunable Lewis acidity-basicity that can be used to control the solubility of dissolved metal ions in the reactor. Changing the MgCl2:KCl mixing ratio alters the absorption spectra of radiolytically-produced excess electrons, with increasing blue shifts related to the probable number of Mg2+ ions close to the cavity electron. These strong blue shifts imply significant changes in the electron’s energetics and reactivity that we quantify by measuring reaction kinetics with metal ion electron acceptors. This work was supported as part of the Molten Salts in Extreme Environments Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.